World Health Organization (WHO)
Second general meeting of the WHO Global Coordination Mechanism on the Prevention and Control of Noncommunicable Diseases: meeting report, 23-25 April 2025
Report
11 Aug 2025
08 May 2020
Concerns exists that angiotensin-converting enzyme inhibitors (ACE inhibitors) and angiotensin receptor blockers (ARBs) increase susceptibility to coronavirus SARS CoV-2 (the viral agent that causes the disease COVID-19) and the likelihood of severe COVID-19 illness. These concerns are based on considerations of biological plausibility, and the observation that there is an overrepresentation of patients with hypertension and other cardiovascular comorbidities among patients with COVID-19 who have poor outcomes.